Based on quantitative analysis, the firm represents a key company in our investment strategy described in our report. Allergan is a pharmaceutical company acquiring, developing and marketing brand name drugs. In 2017, the company generated 80% of net sales from the healthcare system in the US. Thus, the company is not as vulnerable to market crises rising from possible trade conflicts between the US and China. Also, pharmaceutical companies provide essentials for everyday living, which makes them a fundamentally competitive company.